NUBPL inhibitors are not defined by a singular chemical structure or specific mechanism of action directly targeting NUBPL. Instead, they encompass various compounds that can influence mitochondrial function and iron-sulfur cluster assembly, both of which are integral to NUBPL's role within the cell. These substances act through different mechanisms, such as inhibiting various complexes of the mitochondrial respiratory chain or influencing the redox state within mitochondria. These actions can alter the mitochondrial environment and processes, subsequently affecting the function of NUBPL.
The efficacy of these inhibitors is grounded in their capacity to disrupt the electron transport chain or interfere with mitochondrial metabolism, which are processes crucial for the proper function of NUBPL in the assembly of iron-sulfur clusters. By impacting these fundamental aspects of mitochondrial function, the compounds indirectly modulate the activity of NUBPL. These inhibitors include those that act on specific complexes within the mitochondrial respiratory chain, such as Complex II and Complex III, and those that affect the proton gradient and ATP synthesis, which are essential for maintaining the energy and redox balance within the mitochondria.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
Interferes with the electron transport chain in mitochondria, where NUBPL functions, which could impair the assembly of iron-sulfur clusters. | ||||||
2-Thenoyltrifluoroacetone | 326-91-0 | sc-251801 | 5 g | $37.00 | 1 | |
Targets Complex II of the mitochondrial respiratory chain, affecting the environment necessary for NUBPL activity. | ||||||
Carboxine | 5234-68-4 | sc-234286 | 250 mg | $21.00 | 1 | |
Inhibits succinate dehydrogenase, part of Complex II, disrupting mitochondrial processes related to NUBPL. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $55.00 $63.00 $1675.00 $4692.00 | 51 | |
Inhibits Complex III in the mitochondrial respiratory chain, impacting the assembly of iron-sulfur clusters facilitated by NUBPL. | ||||||
Sodium azide | 26628-22-8 | sc-208393 sc-208393B sc-208393C sc-208393D sc-208393A | 25 g 250 g 1 kg 2.5 kg 100 g | $43.00 $155.00 $393.00 $862.00 $90.00 | 8 | |
Inhibits cytochrome c oxidase in the electron transport chain, which could indirectly affect NUBPL function. | ||||||
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $149.00 $12495.00 | 18 | |
Inhibits ATP synthase, disrupting the proton gradient required for mitochondrial function, which could influence NUBPL activity. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Inhibits thioredoxin reductase, which could indirectly affect the redox state within mitochondria and thus NUBPL function. | ||||||
3-Nitropropionic acid | 504-88-1 | sc-214148 sc-214148A | 1 g 10 g | $82.00 $459.00 | ||
Irreversibly inhibits succinate dehydrogenase, which could disrupt mitochondrial function and indirectly impact NUBPL. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to accumulate in mitochondria and could alter their function and the processes in which NUBPL is involved. | ||||||